The patient presented with shoulder and hip pain and stiffness, characteristic of polymyalgia rheumatica (PMR). Ultrasound findings of sub-deltoid bursitis, biceps tenosynovitis, and glenohumeral and hip synovitis, along with elevated inflammatory markers, supported a diagnosis of PMR according to classification criteria. PMR must be distinguished from rheumatoid arthritis, which can be excluded by a lack of distal joint involvement and negative rheumatoid factor and anti-CCP tests. Approximately one-sixth of PMR patients may also have giant cell arteritis (GCA), which can be detected by imaging showing arterial wall changes. Positron emission tomography is
The patient presented with shoulder and hip pain and stiffness, characteristic of polymyalgia rheumatica (PMR). Ultrasound findings of sub-deltoid bursitis, biceps tenosynovitis, and glenohumeral and hip synovitis, along with elevated inflammatory markers, supported a diagnosis of PMR according to classification criteria. PMR must be distinguished from rheumatoid arthritis, which can be excluded by a lack of distal joint involvement and negative rheumatoid factor and anti-CCP tests. Approximately one-sixth of PMR patients may also have giant cell arteritis (GCA), which can be detected by imaging showing arterial wall changes. Positron emission tomography is
The patient presented with shoulder and hip pain and stiffness, characteristic of polymyalgia rheumatica (PMR). Ultrasound findings of sub-deltoid bursitis, biceps tenosynovitis, and glenohumeral and hip synovitis, along with elevated inflammatory markers, supported a diagnosis of PMR according to classification criteria. PMR must be distinguished from rheumatoid arthritis, which can be excluded by a lack of distal joint involvement and negative rheumatoid factor and anti-CCP tests. Approximately one-sixth of PMR patients may also have giant cell arteritis (GCA), which can be detected by imaging showing arterial wall changes. Positron emission tomography is
Patient presented with typical symptoms of PMR - pain and stiffness in shoulders and hips, which are cardinal signs of PMR. 2012 classification criteria suggest positive ultrasound findings with 66% sensitivity and 81% specificity for diagnosing PMR. Raised inflammatory markers in this patient align with the required criteria for diagnosing PMR. 2. Ultrasound Findings in PMR: Shoulder: sub-deltoid bursitis, biceps tenosynovitis, glenohumeral synovitis. Hip: hip synovitis, trochanteric bursitis. 3. Distinguishing PMR from Other Disorders: Absence of distal joint involvement, negative RF, and anti-CCP can exclude RA in patients with PMR symptoms. 4. PMR and GCA: Approximately one-sixth of PMR patients can have GCA, with early manifestations including headache, temporal artery tenderness, and visual loss. Imaging findings of GCA may reveal arterial wall edema and thickening, detectable through FDG-PET, color Doppler sonography, MRI, and CT. 5. FDG-PET in GCA: FDG-PET is highly sensitive for ruling out large vessel vasculitis but lacks vessel anatomy visualization and has drawbacks like high ionizing radiation and cost. Temporal artery biopsies may show less frequent positivity in patients with plasma cell vasculitis. 6. Management of PMR and GCA: 2015 EULAR and ACR recommendations guide the medical treatment for GCA. References: Hellmich B, Agueda A, Monti S, et al. (2018). Update of the EULAR recommendations for the management of large vessel vasculitis in Annals of the Rheumatic Diseases. Dejaco C, et al. (2015). Recommendations for the management of polymyalgia rheumatica: a collaborative initiative between European League Against Rheumatism and American College of Rheumatology in Ann Rheum Dis. 2012 provisional classification criteria for polymyalgia rheumatica: a collaborative initiative between European League Against Rheumatism and American College of Rheumatology in Ann Rheum Dis. Dario Camellino and Marco A. Cimmino (2011). Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis, and prognosis in Rheumatolog
A High Throughput Approach For Resolution of Dermorphin Inside Man Urine Making Use of Water Chromatographymass Spectrometry Pertaining To Doping Manage Usestuouz PDF